Allowing CBD Use In Supplements Benefits Drug Innovation – Trade Groups
You may also be interested in...
US Wellness Market In 2019: Farm Bill Made Cultivating Cannabidiol Policy FDA's Main Course In Supplements
As HBW Insight looks back on notable US wellness market developments and events for the previous 12 months, we find that news in the CBD space from the FDA and the industry dominated the sector throughout 2019.
The agency announces that it cannot conclude cannabidiol is GRAS, potentially heading off GRAS notifications and making NDI notifications a likelier future for CBD use in the supplement sector if any “lawful pathway” is to be found. In addition to a barrage of warning letters to marketers of CBD products, the FDA issued a stark warning to consumers about potential hazards.
NJ senators say although FDA deems dietary ingredients and food additives with CBD as unlawful, in the past three years more than 1,500 CBD products have come to market “without a clear approach for regulation or any plan from the FDA to balance consumer access and protect consumer health.”